Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study
Authors:
- 30 June 2023
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 23 (11) , 1244-1256
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Heart Lung and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Cystic Fibrosis Foundation
- Japan Agency for Medical Research and Development
- Cystic Fibrosis Research Institute
This publication has 30 references indexed in Scilit:
- Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based SurveyEuropean Journal of Internal Medicine, 2021
- Coronavirus Disease (COVID-19): Comprehensive Review of Clinical PresentationFrontiers in Public Health, 2021
- COVID‐19 in older adults: What are the differences with younger patients?Geriatrics & Gerontology International, 2020
- Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patientsJournal of Medical Virology, 2020
- Age-specific mortality and immunity patterns of SARS-CoV-2Nature, 2020
- Initial symptoms of patients with coronavirus disease 2019 in Japan: A descriptive studyJournal of General and Family Medicine, 2020
- Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 InfectionJAMA Network Open, 2020
- Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)Clinical Infectious Diseases, 2020
- Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysisInternational Journal of Public Health, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020